Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Foot Diseases | 12 | 2022 | 143 | 1.970 |
Why?
|
| Foot | 13 | 2017 | 528 | 1.730 |
Why?
|
| Hallux Valgus | 8 | 2022 | 65 | 1.610 |
Why?
|
| Pain | 15 | 2022 | 4961 | 1.080 |
Why?
|
| Shoes | 4 | 2014 | 98 | 0.930 |
Why?
|
| Bathing Beaches | 1 | 2021 | 13 | 0.780 |
Why?
|
| Water Microbiology | 1 | 2021 | 117 | 0.730 |
Why?
|
| Hip Fractures | 5 | 2024 | 954 | 0.650 |
Why?
|
| Pronation | 5 | 2015 | 51 | 0.520 |
Why?
|
| Mobility Limitation | 3 | 2015 | 405 | 0.500 |
Why?
|
| Nursing Homes | 6 | 2022 | 1034 | 0.490 |
Why?
|
| Environmental Monitoring | 1 | 2021 | 1413 | 0.480 |
Why?
|
| Osteoporotic Fractures | 3 | 2024 | 403 | 0.470 |
Why?
|
| Dementia | 3 | 2022 | 2501 | 0.420 |
Why?
|
| Pain Measurement | 5 | 2017 | 3418 | 0.410 |
Why?
|
| Bone Density | 9 | 2024 | 3469 | 0.410 |
Why?
|
| Accidental Falls | 5 | 2021 | 1057 | 0.390 |
Why?
|
| Lower Extremity | 1 | 2017 | 1151 | 0.340 |
Why?
|
| Body Size | 1 | 2012 | 461 | 0.340 |
Why?
|
| Fractures, Bone | 1 | 2021 | 1945 | 0.340 |
Why?
|
| Diet | 9 | 2023 | 7923 | 0.340 |
Why?
|
| Hallux Rigidus | 2 | 2022 | 13 | 0.340 |
Why?
|
| Massachusetts | 13 | 2022 | 8662 | 0.330 |
Why?
|
| Osteoporosis | 3 | 2023 | 1581 | 0.310 |
Why?
|
| Aged | 59 | 2023 | 162944 | 0.300 |
Why?
|
| Videoconferencing | 3 | 2023 | 195 | 0.290 |
Why?
|
| Sarcopenia | 1 | 2012 | 368 | 0.290 |
Why?
|
| Ticlopidine | 3 | 2016 | 899 | 0.270 |
Why?
|
| Gait | 5 | 2015 | 784 | 0.270 |
Why?
|
| Infection Control | 3 | 2022 | 962 | 0.270 |
Why?
|
| Supination | 3 | 2014 | 68 | 0.270 |
Why?
|
| Cross-Sectional Studies | 22 | 2023 | 24913 | 0.260 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2018 | 3695 | 0.250 |
Why?
|
| Flatfoot | 4 | 2013 | 55 | 0.250 |
Why?
|
| Muscle Strength | 2 | 2018 | 586 | 0.230 |
Why?
|
| Posture | 4 | 2017 | 958 | 0.220 |
Why?
|
| Foot Deformities | 2 | 2013 | 36 | 0.220 |
Why?
|
| Independent Living | 3 | 2022 | 564 | 0.220 |
Why?
|
| Dietary Proteins | 3 | 2017 | 963 | 0.220 |
Why?
|
| Aged, 80 and over | 25 | 2023 | 57683 | 0.210 |
Why?
|
| Longitudinal Studies | 10 | 2023 | 13921 | 0.210 |
Why?
|
| Osteoarthritis | 3 | 2015 | 1034 | 0.210 |
Why?
|
| Toilet Facilities | 1 | 2021 | 26 | 0.210 |
Why?
|
| Prospective Studies | 21 | 2024 | 53187 | 0.200 |
Why?
|
| Male | 62 | 2024 | 349538 | 0.200 |
Why?
|
| Logistic Models | 10 | 2022 | 13403 | 0.200 |
Why?
|
| Middle Aged | 46 | 2023 | 213127 | 0.200 |
Why?
|
| Knee Joint | 3 | 2017 | 1679 | 0.200 |
Why?
|
| Carotenoids | 2 | 2022 | 624 | 0.190 |
Why?
|
| Hospitals, Community | 1 | 2023 | 348 | 0.190 |
Why?
|
| Hand Strength | 2 | 2021 | 444 | 0.190 |
Why?
|
| Body Mass Index | 9 | 2016 | 12695 | 0.190 |
Why?
|
| Health Behavior | 4 | 2018 | 2630 | 0.190 |
Why?
|
| Female | 57 | 2024 | 379592 | 0.180 |
Why?
|
| Adipose Tissue | 1 | 2012 | 3278 | 0.180 |
Why?
|
| Aging | 3 | 2015 | 8626 | 0.170 |
Why?
|
| Exercise Therapy | 2 | 2018 | 904 | 0.170 |
Why?
|
| Humans | 76 | 2024 | 742088 | 0.170 |
Why?
|
| Diet Surveys | 5 | 2022 | 1172 | 0.170 |
Why?
|
| Aspirin | 3 | 2022 | 3278 | 0.170 |
Why?
|
| Obesity | 5 | 2022 | 12705 | 0.170 |
Why?
|
| Dairy Products | 1 | 2022 | 498 | 0.160 |
Why?
|
| Prevalence | 7 | 2022 | 15194 | 0.160 |
Why?
|
| Homosexuality | 1 | 1999 | 264 | 0.160 |
Why?
|
| Homes for the Aged | 1 | 2020 | 260 | 0.160 |
Why?
|
| Hepatitis B Vaccines | 1 | 1999 | 194 | 0.160 |
Why?
|
| Walking | 3 | 2015 | 1177 | 0.160 |
Why?
|
| Exercise | 5 | 2018 | 5611 | 0.160 |
Why?
|
| Postprandial Period | 1 | 2019 | 292 | 0.160 |
Why?
|
| Risk Factors | 19 | 2024 | 72145 | 0.150 |
Why?
|
| Femur Neck | 3 | 2018 | 309 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 11695 | 0.150 |
Why?
|
| Risk Assessment | 7 | 2024 | 23320 | 0.150 |
Why?
|
| Body Fluid Compartments | 1 | 2017 | 52 | 0.150 |
Why?
|
| Hammer Toe Syndrome | 2 | 2013 | 12 | 0.150 |
Why?
|
| Cohort Studies | 18 | 2024 | 40450 | 0.140 |
Why?
|
| Diet, Mediterranean | 1 | 2022 | 696 | 0.130 |
Why?
|
| Depression | 4 | 2023 | 7733 | 0.130 |
Why?
|
| Motor Cortex | 1 | 2023 | 984 | 0.130 |
Why?
|
| Quadriceps Muscle | 1 | 2017 | 144 | 0.130 |
Why?
|
| Postural Balance | 3 | 2014 | 620 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2016 | 3067 | 0.130 |
Why?
|
| Feces | 1 | 2021 | 1394 | 0.120 |
Why?
|
| Restraint, Physical | 1 | 2016 | 193 | 0.120 |
Why?
|
| Risk-Taking | 1 | 2000 | 986 | 0.120 |
Why?
|
| Vidarabine | 1 | 2015 | 345 | 0.120 |
Why?
|
| Stents | 2 | 2016 | 3276 | 0.120 |
Why?
|
| Pressure | 5 | 2015 | 1203 | 0.120 |
Why?
|
| Hepatitis B | 1 | 1999 | 695 | 0.120 |
Why?
|
| Arthralgia | 2 | 2018 | 456 | 0.120 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2015 | 430 | 0.110 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 770 | 0.110 |
Why?
|
| Fasciitis, Plantar | 1 | 2013 | 31 | 0.110 |
Why?
|
| Sexual Behavior | 2 | 2000 | 2050 | 0.110 |
Why?
|
| Ankle Joint | 2 | 2013 | 411 | 0.110 |
Why?
|
| Feeding Behavior | 2 | 2017 | 3187 | 0.110 |
Why?
|
| Muscles | 1 | 2017 | 1617 | 0.110 |
Why?
|
| Homosexuality, Male | 1 | 2000 | 1238 | 0.100 |
Why?
|
| Delirium | 1 | 2023 | 1608 | 0.100 |
Why?
|
| Weight-Bearing | 4 | 2015 | 514 | 0.100 |
Why?
|
| Patient Readmission | 2 | 2023 | 3111 | 0.100 |
Why?
|
| Bone Density Conservation Agents | 1 | 2018 | 774 | 0.100 |
Why?
|
| Socioeconomic Factors | 3 | 2015 | 7770 | 0.100 |
Why?
|
| Fatigue | 1 | 2018 | 1526 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2276 | 0.100 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2014 | 651 | 0.100 |
Why?
|
| Osteoarthritis, Hip | 1 | 2015 | 412 | 0.090 |
Why?
|
| Physical Therapy Modalities | 1 | 2014 | 547 | 0.090 |
Why?
|
| Hip Joint | 1 | 2017 | 1002 | 0.090 |
Why?
|
| France | 4 | 2015 | 517 | 0.090 |
Why?
|
| Advance Care Planning | 1 | 2017 | 660 | 0.090 |
Why?
|
| Leg | 1 | 2015 | 1110 | 0.090 |
Why?
|
| North Carolina | 3 | 2015 | 311 | 0.090 |
Why?
|
| Odds Ratio | 6 | 2022 | 9846 | 0.090 |
Why?
|
| Absorptiometry, Photon | 2 | 2015 | 1726 | 0.090 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 1048 | 0.090 |
Why?
|
| Quebec | 2 | 2000 | 133 | 0.090 |
Why?
|
| Adult | 23 | 2023 | 213712 | 0.090 |
Why?
|
| Cartilage Diseases | 1 | 2011 | 160 | 0.090 |
Why?
|
| Food Services | 1 | 2012 | 191 | 0.090 |
Why?
|
| Potassium, Dietary | 1 | 2009 | 96 | 0.090 |
Why?
|
| Energy Intake | 3 | 2015 | 2147 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2023 | 3861 | 0.080 |
Why?
|
| Connective Tissue | 1 | 2011 | 420 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2021 | 4214 | 0.080 |
Why?
|
| Patient Compliance | 2 | 2018 | 2680 | 0.080 |
Why?
|
| Body Height | 2 | 2012 | 1574 | 0.080 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2015 | 1873 | 0.080 |
Why?
|
| Sex Factors | 3 | 2016 | 10392 | 0.080 |
Why?
|
| Young Adult | 12 | 2019 | 56350 | 0.080 |
Why?
|
| Insulin | 2 | 2019 | 6575 | 0.070 |
Why?
|
| Multivariate Analysis | 6 | 2016 | 12242 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 2866 | 0.070 |
Why?
|
| Psychotropic Drugs | 1 | 2013 | 893 | 0.070 |
Why?
|
| Vaccination | 1 | 1999 | 3256 | 0.070 |
Why?
|
| Range of Motion, Articular | 1 | 2013 | 1577 | 0.070 |
Why?
|
| Skilled Nursing Facilities | 2 | 2023 | 372 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2023 | 4551 | 0.070 |
Why?
|
| Milk | 2 | 2022 | 449 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2502 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2013 | 2290 | 0.070 |
Why?
|
| Muscle, Skeletal | 2 | 2018 | 4933 | 0.070 |
Why?
|
| Sodium, Dietary | 1 | 2009 | 418 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 1684 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2015 | 6454 | 0.070 |
Why?
|
| Arthritis | 1 | 2011 | 658 | 0.070 |
Why?
|
| Population Surveillance | 2 | 2013 | 2616 | 0.060 |
Why?
|
| Sexual Partners | 2 | 2000 | 730 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2107 | 0.060 |
Why?
|
| Nutrition Policy | 1 | 2009 | 488 | 0.060 |
Why?
|
| Incidence | 2 | 2021 | 20928 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2019 | 6249 | 0.060 |
Why?
|
| Cause of Death | 1 | 2015 | 3571 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 3336 | 0.060 |
Why?
|
| Propensity Score | 3 | 2016 | 1771 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2013 | 955 | 0.060 |
Why?
|
| Osteoarthritis, Knee | 1 | 2015 | 1222 | 0.060 |
Why?
|
| Quality of Life | 4 | 2022 | 12730 | 0.060 |
Why?
|
| Follow-Up Studies | 8 | 2022 | 39004 | 0.060 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1596 | 0.060 |
Why?
|
| Schools | 1 | 2012 | 1425 | 0.060 |
Why?
|
| Cartilage, Articular | 1 | 2011 | 1095 | 0.060 |
Why?
|
| Proportional Hazards Models | 5 | 2016 | 12344 | 0.060 |
Why?
|
| Drug Administration Schedule | 3 | 2016 | 4929 | 0.060 |
Why?
|
| Physicians | 1 | 2022 | 4554 | 0.060 |
Why?
|
| Acute Coronary Syndrome | 1 | 2016 | 2337 | 0.060 |
Why?
|
| Antipsychotic Agents | 1 | 2016 | 3058 | 0.050 |
Why?
|
| Self Efficacy | 2 | 2018 | 610 | 0.050 |
Why?
|
| Self Report | 3 | 2022 | 3548 | 0.050 |
Why?
|
| Inflammation | 4 | 2023 | 10578 | 0.050 |
Why?
|
| Interleukin-6 | 2 | 2022 | 3199 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 8328 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2017 | 3738 | 0.050 |
Why?
|
| Adolescent | 11 | 2018 | 85649 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 13655 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2023 | 370 | 0.050 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2016 | 874 | 0.050 |
Why?
|
| Fear | 2 | 2021 | 1436 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 2195 | 0.050 |
Why?
|
| Diet Records | 2 | 2015 | 425 | 0.050 |
Why?
|
| Clinical Audit | 1 | 2020 | 31 | 0.050 |
Why?
|
| Time Factors | 6 | 2021 | 40054 | 0.050 |
Why?
|
| Palliative Care | 1 | 2015 | 3478 | 0.050 |
Why?
|
| Evoked Potentials, Motor | 1 | 2023 | 456 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 11039 | 0.040 |
Why?
|
| Education, Continuing | 1 | 2020 | 112 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 947 | 0.040 |
Why?
|
| Bone and Bones | 2 | 2023 | 2575 | 0.040 |
Why?
|
| Prosthesis Design | 2 | 2016 | 2110 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2022 | 647 | 0.040 |
Why?
|
| Hepatitis B Antibodies | 1 | 1999 | 159 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 3497 | 0.040 |
Why?
|
| Social Isolation | 1 | 2021 | 363 | 0.040 |
Why?
|
| Drug-Eluting Stents | 2 | 2015 | 753 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2023 | 1179 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2016 | 2713 | 0.040 |
Why?
|
| Medicare | 3 | 2023 | 6532 | 0.040 |
Why?
|
| HIV Seronegativity | 1 | 1999 | 211 | 0.040 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1999 | 305 | 0.040 |
Why?
|
| Patient Discharge | 2 | 2023 | 3300 | 0.040 |
Why?
|
| Overweight | 1 | 2009 | 2366 | 0.040 |
Why?
|
| Length of Stay | 2 | 2023 | 6294 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 5724 | 0.040 |
Why?
|
| Proxy | 1 | 2017 | 144 | 0.040 |
Why?
|
| Teriparatide | 1 | 2018 | 225 | 0.040 |
Why?
|
| Maine | 1 | 2016 | 139 | 0.030 |
Why?
|
| Veterans Disability Claims | 1 | 2015 | 15 | 0.030 |
Why?
|
| Models, Biological | 1 | 2012 | 9581 | 0.030 |
Why?
|
| Eating | 1 | 2022 | 1535 | 0.030 |
Why?
|
| Sweden | 1 | 2018 | 1343 | 0.030 |
Why?
|
| Androgens | 1 | 2023 | 1271 | 0.030 |
Why?
|
| Reimbursement, Incentive | 1 | 2020 | 540 | 0.030 |
Why?
|
| Nursing Staff | 1 | 2016 | 129 | 0.030 |
Why?
|
| Health Communication | 1 | 2017 | 213 | 0.030 |
Why?
|
| Behavior | 1 | 2017 | 560 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2023 | 1509 | 0.030 |
Why?
|
| United States | 5 | 2023 | 69693 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2023 | 1350 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2016 | 404 | 0.030 |
Why?
|
| Diphosphonates | 1 | 2018 | 625 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2022 | 2899 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2023 | 1431 | 0.030 |
Why?
|
| Bunion, Tailor's | 1 | 2012 | 2 | 0.030 |
Why?
|
| Checklist | 1 | 2020 | 830 | 0.030 |
Why?
|
| Resuscitation Orders | 1 | 2015 | 267 | 0.030 |
Why?
|
| Chickens | 1 | 2015 | 865 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2018 | 62966 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2014 | 215 | 0.030 |
Why?
|
| Comorbidity | 2 | 2018 | 10372 | 0.030 |
Why?
|
| Calcium, Dietary | 1 | 2015 | 527 | 0.030 |
Why?
|
| Fishes | 1 | 2015 | 569 | 0.030 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2014 | 282 | 0.030 |
Why?
|
| Seafood | 1 | 2015 | 384 | 0.030 |
Why?
|
| Meat | 1 | 2015 | 595 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 939 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2015 | 723 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 2016 | 603 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2015 | 607 | 0.020 |
Why?
|
| Extremities | 1 | 2017 | 865 | 0.020 |
Why?
|
| Educational Status | 2 | 2009 | 2533 | 0.020 |
Why?
|
| Metals | 1 | 2015 | 717 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2016 | 7716 | 0.020 |
Why?
|
| Patient Preference | 1 | 2017 | 886 | 0.020 |
Why?
|
| Fast Foods | 1 | 2012 | 197 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2014 | 1791 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 3766 | 0.020 |
Why?
|
| Orthotic Devices | 1 | 2011 | 128 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2023 | 6974 | 0.020 |
Why?
|
| Knee | 1 | 2011 | 274 | 0.020 |
Why?
|
| Quinolines | 1 | 2014 | 719 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 15530 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2014 | 1179 | 0.020 |
Why?
|
| Food Analysis | 1 | 2009 | 104 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2015 | 1484 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 1905 | 0.020 |
Why?
|
| Age Factors | 2 | 2009 | 18355 | 0.020 |
Why?
|
| Imidazoles | 1 | 2014 | 1205 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2023 | 8541 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 2167 | 0.020 |
Why?
|
| Sirolimus | 1 | 2014 | 1562 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2014 | 1827 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2017 | 2706 | 0.020 |
Why?
|
| Child Behavior | 1 | 2012 | 838 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2015 | 1606 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6365 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2014 | 1581 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 3557 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6483 | 0.020 |
Why?
|
| Television | 1 | 2009 | 409 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2023 | 77098 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 8333 | 0.020 |
Why?
|
| Health Status | 1 | 2018 | 4030 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 19862 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 2714 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6891 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 2938 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6534 | 0.020 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 11690 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2016 | 3461 | 0.020 |
Why?
|
| Disease Management | 1 | 2015 | 2450 | 0.020 |
Why?
|
| Mental Health | 1 | 2018 | 2997 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 4664 | 0.010 |
Why?
|
| Anxiety | 1 | 2018 | 4279 | 0.010 |
Why?
|
| Adolescent Behavior | 1 | 2012 | 1150 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2017 | 3203 | 0.010 |
Why?
|
| Child, Preschool | 3 | 2012 | 40955 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8297 | 0.010 |
Why?
|
| Registries | 1 | 2018 | 8077 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2015 | 3294 | 0.010 |
Why?
|
| Boston | 1 | 2015 | 9305 | 0.010 |
Why?
|
| Animals | 3 | 2022 | 168561 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 10248 | 0.010 |
Why?
|
| Vitamin D | 1 | 2015 | 3211 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2023 | 15244 | 0.010 |
Why?
|
| Survival Rate | 1 | 2015 | 12773 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 10943 | 0.010 |
Why?
|
| Kidney | 1 | 2015 | 7167 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9715 | 0.010 |
Why?
|
| Child | 3 | 2012 | 77478 | 0.010 |
Why?
|
| Life Style | 1 | 2009 | 3824 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 29010 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23387 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 81045 | 0.000 |
Why?
|
Concepts
(303)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(50)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_